Kenya launches national cervical cancer elimination plan 2026–2030.

Kenya has launched the National Cervical Cancer Elimination Action Plan 2026–2030 with support from the World Health Organization; cervical cancer is the second most common cancer among women in Kenya, with about 2,300 new cases and 1,600 deaths reported each year.

Kenya's government has launched the National Cervical Cancer Elimination Action Plan 2026–2030 with support from the World Health Organization. The five-year strategy aims to accelerate prevention, early detection and treatment of cervical cancer. Cervical cancer is the second most common cancer among women in Kenya, with about 2,300 new cases and 1,600 deaths reported annually. The plan is costed, results-oriented, and emphasizes equity, quality and national scale-up. Key points: - The plan covers 2026–2030 and was developed in collaboration with WHO. - Kenya transitioned to a single-dose HPV vaccination schedule in November 2025, and WHO supported training for more than 11,000 health workers. - The strategy highlights expanding HPV DNA testing, introducing self-sampling, strengthening referral pathways, and using digital health tools across all 47 counties. Summary: The plan sets out steps to scale up vaccination, screening and treatment nationwide and to strengthen health worker capacity and service access. Undetermined at this time.